Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | ||||
|---|---|---|---|---|---|
| Revenue | -7.07% | -8.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.07% | -8.64% | |||
| Cost of Revenue | -20.86% | 15.02% | |||
| Gross Profit | 27.86% | -39.95% | |||
| SG&A Expenses | 10.42% | -8.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.56% | -2.46% | |||
| Operating Income | -2.62% | -5.77% | |||
| Income Before Tax | -17.77% | 6.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.77% | 6.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.77% | 6.36% | |||
| EBIT | -2.62% | -5.77% | |||
| EBITDA | -2.87% | -6.44% | |||
| EPS Basic | -17.73% | 6.48% | |||
| Normalized Basic EPS | -3.19% | -6.63% | |||
| EPS Diluted | -17.73% | 6.48% | |||
| Normalized Diluted EPS | -3.19% | -6.63% | |||
| Average Basic Shares Outstanding | 0.02% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||